RICT 2018

Interfacing Chemical Biology and Drug Discovery

54th International Conference on Medicinal Chemistry
54èmes Rencontres Internationales de Chimie Thérapeutique

 Strasbourg, France    July 4-6, 2018

Plenary Speakers

PL09 - Paul Ehrlich Award Lecture - Chemical Biology on the Genome

Prof. Sir Shankar BALASUBRAMANIAN
Prof. Sir Shankar BALASUBRAMANIAN
UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom
Read more

PL17 - Nanoparticle-based Strategies in Oncology

Prof. Jean-Pierre BENOIT
Prof. Jean-Pierre BENOIT
UNIVERSITY OF ANGERS, Angers, France
Read more

PL22 - Two Adventures in Chemical Biology - in vivo Chemistry and Real-time Optical Medical Imaging

Prof. Mark BRADLEY
Prof. Mark BRADLEY
UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom
Read more

PL01 - Disrupting Cancer Care & Outcomes by Putting Patients in the Driving Seat

Dr Anne BRUINVELS
Dr Anne BRUINVELS
PX HEALTHCARE, London, United Kingdom
Read more

PL21 - Pierre Fabre Award lecture
PROTAC-mediated Protein Degradation: A New Therapeutic Modality

Prof. Craig CREWS
Prof. Craig CREWS
UNIVERSITY OF YALE, New Haven, United States
Read more

PL04 - Ghrelin Receptor Ligands: from the Bench to the Drug on the Market

Dr Jean-Alain FEHRENTZ
Dr Jean-Alain FEHRENTZ
CNRS-UNIVERSITY OF MONTPELLIER, Montpellier, France
Read more

PL11 - Identification of Chemokine Neutraligands Targeting Atopic Diseases and Hyperalgesia

Dr Jean-Luc GALZI
Dr Jean-Luc GALZI
CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France
Read more

PL10 - Ancient and Modern Scaffolds for Biologically Active Chemical Space

Prof. Arasu GANESAN
Prof. Arasu GANESAN
UNIVERSITY OF EAST ANGLIA, Norwich, United Kingdom
Read more

PL06 - Structure-guided Development of Selective GPCR Ligands

Prof. Peter GMEINER
Prof. Peter GMEINER
FRIEDRICH ALEXANDER UNIVERSITY, Erlangen, Germany
Read more

PL07 - Late Stage Fluorination for Medicine

Prof. Véronique GOUVERNEUR
Prof. Véronique GOUVERNEUR
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

PL15 - Identifying Inter-Helical Interactions Involved in GPCR Structure-Function and the Forces that Determine Receptor-Ligand Residence Time

Dr Alexander HEIFETZ
Dr Alexander HEIFETZ
EVOTEC, Abingdon, United Kingdom
Read more

PL05 - Structure-Based Drug Discovery for G Protein-Coupled Purine Receptors

Prof. Kenneth A. JACOBSON
Prof. Kenneth A. JACOBSON
NIDDK, Bethesda, United States
Read more

PL19 - Chemical Tools to Probe Reversible Lysine Acetylation

Prof. Manfred JUNG
Prof. Manfred JUNG
ALBERT LUDWIGS UNIVERSITY OF FREIBURG, Freiburg, Germany
Read more

PL14 - Pharmacophore-based Analysis of Molecular Dynamics Trajectories: Towards Understanding KD of Protein Ligands

Prof. Thierry LANGER
Prof. Thierry LANGER
UNIVERSITY OF VIENNA, Vienna, Austria
Read more

PL13 - Potential Therapeutic Targets in the Brain Renin-Agiotensin and Apelinergic Systems for Treatment of Cardiovascular Diseases

Dr Catherine  LLORENS-CORTES
Dr Catherine LLORENS-CORTES
INSERM/COLLÈGE DE FRANCE, Paris, France
Read more

PL18 - Chemistry as the Helping Tool to Develop New Therapeutic Strategies

Prof. Maria Luz LOPEZ RODRIGUEZ
Prof. Maria Luz LOPEZ RODRIGUEZ
COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain
Read more

PL20 - The Confobody Technology, a New Platform to Enable Fragment Screening on GPCRs

Dr Christel MENET
Dr Christel MENET
CONFO THERAPEUTICS, Brussels, Belgium
Read more

PL02 - Chemogenetic Approachs to Validate Poorly Characterised GPCRS

Prof. Graeme MILLIGAN
Prof. Graeme MILLIGAN
UNIVERSITY OF GLASGOW, Glasgow, United Kingdom
Read more

PL08 - Single Electron Processes Enabling Organic Synthesis

Prof. Gary A. MOLANDER
Prof. Gary A. MOLANDER
UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States
Read more

PL12 - Discovery of Foliglurax, an mGluR4 PAM for the Treatment of Parkinson’s Disease

Dr Stephan SCHANN
Dr Stephan SCHANN
DOMAIN THERAPEUTICS SA, Illkirch, France
Read more

PL03 - Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism

Dr Patrick SCHNIDER
Dr Patrick SCHNIDER
ROCHE PHARMACEUTICAL, Basel, Switzerland
Read more

PL23 - Therapeutic In Vivo Synthetic Chemistry

Prof. Nori TANAKA
Prof. Nori TANAKA
RIKEN, Saitama, Japan
Read more

PL16 - Cellular Delivery and Oral Uptake of Cyclic Peptides

Dr Thomas  VORHERR
Dr Thomas VORHERR
NOVARTIS, Basel, Switzerland
Read more

Keynote Speakers

KL05 - Topical Intestinal Agonists of the Bile Acid Receptor TGR5: Controlling Target Engagement by Innovative Molecular Engineering

Dr Julie CHARTON
Dr Julie CHARTON
UNIVERSITY OF LILLE, INSTITUT PASTEUR DE LILLE, Lille, France
Read more

KL06 - Drug-target Residence Time – a Misleading Concept

Dr Rutger FOLMER
Dr Rutger FOLMER
MERCACHEM, Nijmegen, The Netherlands
Read more

KL04 - Inducible Chemical-genetic Fluorescent Markers for Bioimaging

Dr Arnaud GAUTIER
Dr Arnaud GAUTIER
ECOLE NORMALE SUPÉRIEURE, Paris, France
Read more

KL02 - Discovery of New Brain Penetrating Neuropeptide S Receptor (NPSR) Antagonists

Dr Julien POTHIER
Dr Julien POTHIER
IDORSIA PHARMACEUTICALS LTD., Allschwil, Switzerland
Read more

KL01 - Discovery of The Clinical Candidate Ribuvaptan, a Dual Acting Vasopressin V1a/V2 Receptor Antagonist for the Treatment of Heart Failure

Dr Carsten SCHMECK
Dr Carsten SCHMECK
BAYER, Wuppertal, Germany
Read more

KL03 - Dye-loaded Lipid Nanoparticles: Contrast Agents for Image-guided Surgery and Tools for Drug Delivery

Dr Isabelle TEXIER
Dr Isabelle TEXIER
LETI-HEALTH, Grenoble, France
Read more